Pages that link to "Q36251164"
Jump to navigation
Jump to search
The following pages link to Cyclins and CDKS in development and cancer: lessons from genetically modified mice (Q36251164):
Displaying 50 items.
- Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy (Q21245716) (← links)
- Functional characterization of human PFTK1 as a cyclin-dependent kinase (Q24306566) (← links)
- An oncologist׳s friend: How Xenopus contributes to cancer research (Q26849774) (← links)
- Potent anti-proliferative, pro-apoptotic activity of the Maytenus royleanus extract against prostate cancer cells: evidence in in-vitro and in-vivo models (Q27311628) (← links)
- Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure (Q27851564) (← links)
- Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis (Q28267277) (← links)
- Cyclin-dependent kinases 4 and 6 control tumor progression and direct glucose oxidation in the pentose cycle (Q28268021) (← links)
- Regulation of cyclin D2 expression and degradation by follicle-stimulating hormone during rat granulosa cell proliferation in vitro (Q28571887) (← links)
- Cell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasia (Q28572109) (← links)
- A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo (Q30495531) (← links)
- Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM (Q33336561) (← links)
- A limited role for p53 in modulating the immediate phenotype of Apc loss in the intestine (Q33340817) (← links)
- Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells (Q33632727) (← links)
- Cryptotanshinone inhibits cancer cell proliferation by suppressing Mammalian target of rapamycin-mediated cyclin D1 expression and Rb phosphorylation (Q34049893) (← links)
- To develop with or without the prion protein. (Q34391248) (← links)
- MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2 (Q34733320) (← links)
- Overexpression or silencing of FOXO3a affects proliferation of endothelial progenitor cells and expression of cell cycle regulatory proteins (Q35219442) (← links)
- Neuronal cell cycle: the neuron itself and its circumstances (Q35565056) (← links)
- Increased cyclin-dependent kinase 6 expression in bladder cancer (Q36099328) (← links)
- Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene (Q36413813) (← links)
- Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes (Q36419687) (← links)
- Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines (Q36653012) (← links)
- Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs (Q36716750) (← links)
- Cell-specific responses to loss of cyclin-dependent kinases. (Q36734736) (← links)
- New combination therapies with cell-cycle agents (Q36737314) (← links)
- Dual control of Shuanghuang Shengbai granule on upstream and downstream signal modulators of CyclinD-CDK4/6 signaling pathway of cell cycle in Lewis-bearing mice with cyclophosphamide-induced myelosuppression (Q36738599) (← links)
- Affinity and dose of TCR engagement yield proportional enhancer and gene activity in CD4 T cells (Q37062660) (← links)
- Regulation of the retinoblastoma proteins by the human herpesviruses. (Q37085853) (← links)
- Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states (Q37198026) (← links)
- Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma (Q37212230) (← links)
- The atypical CDK activator Spy1 regulates the intrinsic DNA damage response and is dependent upon p53 to inhibit apoptosis (Q37435962) (← links)
- Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo. (Q37591650) (← links)
- The role of cell cycle in retinal development: cyclin-dependent kinase inhibitors co-ordinate cell-cycle inhibition, cell-fate determination and differentiation in the developing retina (Q37682759) (← links)
- Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates (Q37718853) (← links)
- Distinct proliferative and transcriptional effects of the D-type cyclins in vivo (Q37724102) (← links)
- The impact of multi-targeted cyclin-dependent kinase inhibition in breast cancer cells: clinical implications (Q37948079) (← links)
- Human gene control by vital oncogenes: revisiting a theoretical model and its implications for targeted cancer therapy (Q37982050) (← links)
- Cyclin dependent kinases in cancer: potential for therapeutic intervention (Q37987789) (← links)
- Tumor suppressive pathways in the control of neurogenesis. (Q38026794) (← links)
- ADAM28 Manipulates Proliferation, Differentiation, and Apoptosis of Human Dental Pulp Stem Cells (Q38337248) (← links)
- AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3beta activation and RNA polymerase II inhibition. (Q38597474) (← links)
- Why (multi)targeting of cyclin-dependent kinases is a promising therapeutic option for hormone-positive breast cancer and beyond (Q38675849) (← links)
- Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells (Q38733868) (← links)
- Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer (Q38743546) (← links)
- Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias. (Q38871799) (← links)
- Cyclin-dependent kinases regulate Ig class switching by controlling access of AID to the switch region (Q38896854) (← links)
- Advances in the treatment of advanced oestrogen-receptor-positive breast cancer (Q39034840) (← links)
- Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells (Q39035155) (← links)
- Cyclin D1 inhibits hepatic lipogenesis via repression of carbohydrate response element binding protein and hepatocyte nuclear factor 4α. (Q39321748) (← links)
- c-ETS1 Facilitates G1/S-phase Transition by Up-regulating Cyclin E and CDK2 Genes and Cooperates with Hepatitis B Virus X Protein for Their Deregulation (Q39554010) (← links)